-
effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
January 01, 2012 - Data from ongoing
larger trials will continue to define the potential role of tofacitinib in improving
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/ems-911-workforce-topic-development-brief.pdf
February 01, 2022 - To define the inclusion criteria for identifying studies about the Guiding Questions,
we specified the
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/hospital/2021-HSOPS2-Database-Report-Part-I-508-rev0921.pdf
January 01, 2021 - Define your goals and select your initiatives:
1.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/3w8Wr9wwAyAqUJWmJo_bL-
February 01, 2014 - Investigators
worked with AHRQ staff and USPSTF members to define
the scope, analytic framework, and
-
www.ahrq.gov/sites/default/files/2024-01/quintana-report.pdf
January 01, 2024 - It would be useful to have a community resource information standard that would define
an information
-
www.ahrq.gov/sites/default/files/2024-07/alexander-report.pdf
January 01, 2024 - reporting system that joins these important variables, to be assessed on a national scale, which can help
define
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary52/vitamin-d-and-calcium-to-prevent-fractures-preventive-medication-2013
December 10, 2011 - fracture at any site, 5 reported data on hip fracture, 2 reported nonvertebral fracture, and 1 did not define
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
January 01, 2011 - for a CER must begin with the concepts identified in the
analytic framework and key questions that define
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
June 01, 2022 - Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 3
Systematic Review on Opioid
Treatments for Chronic Pain:
Surveillance Report 3
Literature Update Period: December 2021 to March 16 2022
Background and Purpose
This is the third and final surveillance report for the 2020 report Opioid…
-
hcup-us.ahrq.gov/reports/methods/MS2024-01-NHQDRMethodsReport.pdf
November 25, 2024 - Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the 2024 National Healthcare Quality and Disparities Report (NHQDR)
HCUP Methods Series
Methods Report Describing 2016-2021 HCUP Data in the
National Healthcare Quality and Disparities Report (NHQDR)
Report #202…
-
hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-User-Guide-v2019-1.pdf
September 01, 2019 - The
guidelines for ICD-10-CM coding10 define these terms as follows:
o “Adverse effect” is used when
-
www.ahrq.gov/sites/default/files/publications2/files/guide-to-real-world-evaluations.pdf
October 01, 2014 - interventions
can be expected to generate bigger effects for high-risk patients, so knowing how you will define
-
www.ahrq.gov/sites/default/files/wysiwyg/mcc/pccp4p/measures-rapid-scan-report.pdf
April 10, 2025 - Some use the term
multimorbidity as synonymous with MCC,
while others define MCC as including
additional
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/failure-to-rescue-1.pdf
March 01, 2020 - inadequate RRT activation, despite activation criteria having been met.6 However, very few studies
define
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_executive.pdf
December 01, 2014 - validated patient outcome measures, have adequate
power to detect significant treatment effects, and define
-
effectivehealthcare.ahrq.gov/products/telehealth/technical-brief
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
April 15, 2013 - Investigators worked with AHRQ staff and a technical expert panel to define the scope, analytic framework
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/MWRHULpw6y_5Uk_KXTyvp8
January 10, 2017 - Rather than using a daily 400-μg dosage to define adequate
intake, another approach is to set the threshold
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_disposition-comments.pdf
January 01, 2010 - Disposition of Comments Report for Methods for Insulin Delivery and Glucose Monitoring
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=749
Published Online: July 10, 2012
Comparative Effectiveness Research Review Disposition of Comments R…
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
June 01, 2014 - AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Cross-Cutting Interventions and Programs
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov
Contract No. HH…